Lobby organisation
BIOTON S.A.
Company · Health & pharma · HQ: Poland · Transparency Register entry
As of 7 November 2026, BIOTON S.A. appears in 3 declared MEP meetings (3 different MEPs), most often with European People's Party.
In their own words
“Bioton S.A. - European Biotech Company producing human insulin: API and finished forms in cartridges and vials. For more than 20years, we have been providing people with diabetes with efficacious and safe medicines. Bioton S.A. is an unquestionable leader on thePolish market, and in the world’s top eight commercial manufacturers of recombinant human insulin.”
Read the rest of the statementShow less of the statement
“Bioton S.A.continuously invests in the development of Polish biotechnology. We were the first company in Poland which, in cooperation with one of Polish scientific institutes, managed to commercialize the results ofthe Biotech Transfer. We apply the most current therapeutic and technological solutions to alleviate diabetes treatment for patients. We strive to build comprehensive solutions for the prevention and treatment of diabetes. Bioton S.A. offers CMO/CDMO and QC services. Our activities are based on QbD in line with cGMP standards. Bioton S.A. supplies also a range of innovative gastroenterological FSMP.”
Stated goals from the organisation's own Transparency Register filing.
Who they meet, and when
Which groups they meet
Share of this organisation's 3 declared meetings, by the meeting MEP's political group.
Meetings by year
Declared meetings per calendar year, 2025–2026. Bar length is relative to its busiest year (2 in 2025). Hatched: 2026 is a part-year - the record runs to 6 Nov 2026.
Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.
The MEPs they meet most
The 3 most recent declared meetings
| Date | MEP | Subject |
|---|---|---|
| 13 May 2026 | Vytenis Povilas Andriukaitis | Biotech Act |
| 22 May 2025 | Tomislav Sokol | Health policy |
| 7 Mar 2025 | Adam Jarubas | Bezpieczeństwo lekowe Europy |
Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.